Novartis Pharmaceuticals

The Pharmaceuticals Division of Novartis is recognized worldwide for the innovative medicines we provide to patients, physicians and healthcare organizations. This growing business develops and markets patent-protected prescription drugs for important health needs. Our products are concentrated in major therapeutic areas including:

Cardiovascular and Metabolism

Oncology
(including Hematology)

Neuroscience and Ophthalmics

Respiratory

Immunology and Infectious Diseases

 

The current product portfolio includes more than 50 key marketed products, many of which are leaders in their respective therapeutic areas. In 2009, Novartis received a total of 25 positive regulatory decisions in the United States, Europe and Japan.

The product development pipeline has 147 projects in various stages of clinical development, including potential new products as well as potential new indications or formulations for existing products.

We are also committed to developing and commercializing evidence-driven diagnostic tests that improve physicians' ability to optimize patient outcomes.